ALNY
Price
$307.89
Change
+$2.58 (+0.85%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
40.15B
56 days until earnings call
ARGX
Price
$580.37
Change
+$6.86 (+1.20%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
35.31B
56 days until earnings call
Interact to see
Advertisement

ALNY vs ARGX

Header iconALNY vs ARGX Comparison
Open Charts ALNY vs ARGXBanner chart's image
Alnylam Pharmaceuticals
Price$307.89
Change+$2.58 (+0.85%)
Volume$6.42K
Capitalization40.15B
argenx SE
Price$580.37
Change+$6.86 (+1.20%)
Volume$1.12K
Capitalization35.31B
ALNY vs ARGX Comparison Chart
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. ARGX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Buy and ARGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ALNY: $305.31 vs. ARGX: $573.51)
Brand notoriety: ALNY and ARGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 56% vs. ARGX: 51%
Market capitalization -- ALNY: $39.81B vs. ARGX: $35.63B
ALNY [@Biotechnology] is valued at $39.81B. ARGX’s [@Biotechnology] market capitalization is $35.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileARGX’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ARGX’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ARGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 6 TA indicator(s) are bullish while ARGX’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 6 bullish, 4 bearish.
  • ARGX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than ARGX.

Price Growth

ALNY (@Biotechnology) experienced а +6.92% price change this week, while ARGX (@Biotechnology) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

ARGX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($40.1B) has a higher market cap than ARGX($35.3B). ALNY YTD gains are higher at: 29.748 vs. ARGX (-6.747). ARGX has higher annual earnings (EBITDA): 365M vs. ALNY (-152.58M). ARGX has more cash in the bank: 3.1B vs. ALNY (2.63B). ARGX has less debt than ALNY: ARGX (34M) vs ALNY (1.3B). ARGX has higher revenues than ALNY: ARGX (2.58B) vs ALNY (2.35B).
ALNYARGXALNY / ARGX
Capitalization40.1B35.3B114%
EBITDA-152.58M365M-42%
Gain YTD29.748-6.747-441%
P/E RatioN/A34.97-
Revenue2.35B2.58B91%
Total Cash2.63B3.1B85%
Total Debt1.3B34M3,829%
FUNDAMENTALS RATINGS
ALNY vs ARGX: Fundamental Ratings
ALNY
ARGX
OUTLOOK RATING
1..100
216
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
74
Overvalued
PROFIT vs RISK RATING
1..100
2218
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
3858
P/E GROWTH RATING
1..100
10084
SEASONALITY SCORE
1..100
9575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARGX's Valuation (74) in the Pharmaceuticals Other industry is in the same range as ALNY (99) in the Biotechnology industry. This means that ARGX’s stock grew similarly to ALNY’s over the last 12 months.

ARGX's Profit vs Risk Rating (18) in the Pharmaceuticals Other industry is in the same range as ALNY (22) in the Biotechnology industry. This means that ARGX’s stock grew similarly to ALNY’s over the last 12 months.

ARGX's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as ALNY (100) in the Biotechnology industry. This means that ARGX’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Price Growth Rating (38) in the Biotechnology industry is in the same range as ARGX (58) in the Pharmaceuticals Other industry. This means that ALNY’s stock grew similarly to ARGX’s over the last 12 months.

ARGX's P/E Growth Rating (84) in the Pharmaceuticals Other industry is in the same range as ALNY (100) in the Biotechnology industry. This means that ARGX’s stock grew similarly to ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYARGX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 16 days ago
71%
Declines
ODDS (%)
Bearish Trend 28 days ago
67%
Bearish Trend 2 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFRFX58.22N/A
N/A
MFS Research A
POICX11.37N/A
N/A
Virtus Tactical Allocation C
KTCAX39.57N/A
N/A
DWS Science and Technology A
CSSVX27.47N/A
N/A
Carillon Chartwell Small Cap R-6
ARIOX11.59N/A
N/A
Aristotle/Saul Global Eq I

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+0.51%
IONS - ALNY
53%
Loosely correlated
+1.01%
ARGX - ALNY
46%
Loosely correlated
-0.54%
SGMO - ALNY
42%
Loosely correlated
-1.64%
VXRT - ALNY
40%
Loosely correlated
-3.07%
ALXO - ALNY
39%
Loosely correlated
-3.71%
More

ARGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARGX has been loosely correlated with ARGNF. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGX jumps, then ARGNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARGX
1D Price
Change %
ARGX100%
-0.54%
ARGNF - ARGX
55%
Loosely correlated
N/A
IONS - ARGX
46%
Loosely correlated
+1.01%
BBIO - ARGX
46%
Loosely correlated
+1.33%
ALNY - ARGX
45%
Loosely correlated
+0.51%
ROIV - ARGX
44%
Loosely correlated
-0.31%
More